Showing results (1771-1780 of 1,880) with videos related to
Sort By:
Pageof 188
Blood|March 27, 2020
Stage I-II nodular lymphocyte-predominant Hodgkin lymphoma: a multi-institutional study of adult patients by ILROGMichael S Binkley, M Shahzad Rauf, Sarah A Milgrom, et al.Journal of the National Comprehensive Cancer Network : JNCCN|November 15, 2021
NCCN Guidelines® Insights: B-Cell Lymphomas, Version 5.2021Andrew D Zelenetz, Leo I Gordon, Julie E Chang, et al.Journal of Medicinal Chemistry|April 22, 2017
Discovery of a Hepatitis C Virus NS5B Replicase Palm Site Allosteric Inhibitor (BMS-929075) Advanced to Phase 1 Clinical StudiesKap-Sun Yeung, Brett R Beno, Kyle Parcella, et al.Genome Biology|July 7, 2007
Transcriptional recapitulation and subversion of embryonic colon development by mouse colon tumor models and human colon cancerSergio Kaiser, Young-Kyu Park, Jeffrey L Franklin, et al.Journal of the National Comprehensive Cancer Network : JNCCN|November 7, 2023
NCCN Guidelines® Insights: B-Cell Lymphomas, Version 6.2023Andrew D Zelenetz, Leo I Gordon, Jeremy S Abramson, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 18, 2024
Management, Outcomes, and Predictors of Mortality of Cryptococcus Infection in Patients Without HIV: A Multicenter Study in 46 Hospitals in Australia and New ZealandJulien Coussement, Christopher H Heath, Matthew B Roberts, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 26, 2023
Current Epidemiology and Clinical Features of Cryptococcus Infection in Patients Without Human Immunodeficiency Virus: A Multicenter Study in 46 Hospitals in Australia and New ZealandJulien Coussement, Christopher H Heath, Matthew B Roberts, et al.Journal of Medicinal Chemistry|January 9, 2014
Discovery and preclinical characterization of the cyclopropylindolobenzazepine BMS-791325, a potent allosteric inhibitor of the hepatitis C virus NS5B polymeraseRobert G Gentles, Min Ding, John A Bender, et al.JHEP Reports : Innovation in Hepatology|October 9, 2024
Loss of biochemical response at any time worsens outcomes in UDCA-treated patients with primary biliary cholangitisSurain B Roberts, Woo Jin Choi, Lawrence Worobetz, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 26, 2024
International Prognostic Score for Nodular Lymphocyte-Predominant Hodgkin LymphomaMichael Sargent Binkley, Jamie E Flerlage, Kerry J Savage, et al.Pageof 188